Retatrutide is a groundbreaking glucagon-like peptide-1 receptor agonist. This pharmaceutical has shown potential in treating type 2 diabetes. By mimicking the actions of naturally occurring GLP-1, Retatrutide improves insulin secretion and limits glucagon release, ultimately leading to better blood sugar control. Clinical trials have revealed that